Loading…
← Back to schedule
Panel: Cracking the Code: Effective Biotech and Big Pharma Partnerships Unveiled
Monday September 30, 2024 1:45pm - 2:30pm EDT
Biotech innovators and Big Pharma companies have been forging partnerships for decades, seeking to enhance R&D productivity, broaden market reach, and better manage commercialization costs. In this panel discussion, we will analyze the components of a successful collaboration between biotech and Big Pharma. Drawing from case studies and industry insights, experts will share their strategic blueprint for cultivating effective partnerships within this ecosystem.

Moderated by: Fierce Editorial Team
Speakers
avatar for Julie Gilmore, Ph.D.

Julie Gilmore, Ph.D.

Vice President Lilly Gateway Labs, Eli Lilly
Julie Gilmore, Ph.D. is Vice President and Global Head for Gateway Labs by Lilly. Gateway Labs by Lilly is designed to speed the discovery of innovative medicines through collaboration with biotech companies in key geographies including San Francisco and Boston.Julie joined Eli Lilly... Read More →
avatar for Samuel Zhang, PhD

Samuel Zhang, PhD

Global Chief Business Officer, Innovent
Samuel Zhang, PhD, is responsible for global strategy and business development as Innovent. Dr. Zhang has a PhD in Molecular Biology from Columbia University, an MBA from the Wharton School of the University of Pennsylvania, and a BS in Biology from Peking University.Dr. Zhang brings... Read More →
avatar for Mark McKenna

Mark McKenna

Chairman and Chief Executive Officer, Mirador Therapeutics
Monday September 30, 2024 1:45pm - 2:30pm EDT
  Track: Strategy & Dealmaking

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link